Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

被引:0
|
作者
Mitra Mohit
Zahra Sarraf
Gelavizh Sheikhi
Minoo Robati
Amir Vasheghani-Farahani
机构
[1] Shiraz University of Medical Sciences,Department of Obstetrics and Gynecology
[2] Islamic Azad University,Department of Obstetrics and Gynecology
[3] Medical Sciences Branch of Tehran,Department of Obstetrics and Gynecology
[4] Booali Hospital,undefined
来源
关键词
Gestational trophoblastic neoplasia; Low-risk gestational trophoblastic neoplasia (LRGTN); Single-agent chemotherapy; Methotrexate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:775 / 780
页数:5
相关论文
共 50 条
  • [21] Actinomycin D for Methotrexate-Failed Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Chapman-Davis, Eloise
    Hoekstra, Anna V.
    Schink, Julian C.
    [J]. JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (7-8) : 283 - 287
  • [22] Low-Risk Gestational Trophoblastic Neoplasia in Manitoba Experience With Alternating Methotrexate and Dactinomycin
    Carlson, Vanessa
    Walters, Leslea
    Lambert, Pascal
    Dean, Erin
    Lotocki, Robert
    Altman, Alon D.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1448 - 1452
  • [23] Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
    Wallin, Emelie
    Niemann, Isa
    Faaborg, Louise
    Fokdal, Lars
    Joneborg, Ulrika
    [J]. CANCERS, 2022, 14 (03)
  • [24] Predictive factors associated with resistance to initial methotrexate treatment in women with low-risk gestational trophoblastic neoplasia
    Phianpiset, Rattiya
    Ruengkhachorn, Irene
    Kuljarusnont, Sompop
    Jareemit, Nida
    Udompunturak, Suthipol
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E495 - E506
  • [25] Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia
    Baptista, Angela M.
    Belfort, Paulo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 35 - 38
  • [26] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia
    Lurain, John R.
    Schink, Julian C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4349 - +
  • [27] Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity
    Chalouhi, Gihad Elias
    Golfier, Francois
    Soignon, Pauline
    Massardier, Jerome
    Guastalla, Jean-Paul
    Trillet-Lenoir, Veronique
    Schott, Anne-Marie
    Raudrant, Daniel
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 643.e1 - 643.e6
  • [28] Combined methotrexate-dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia
    Eiriksson, Lua
    Wells, Tiffany
    Steed, Helen
    Schepansky, Alexandra
    Capstick, Valerie
    Hoskins, Paul
    Pike, Judith
    Swenerton, Kenneth
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 553 - 557
  • [29] WEEKLY INTRAMUSCULAR METHOTREXATE FOR NONMETASTATIC GESTATIONAL TROPHOBLASTIC DISEASE
    HOMESLEY, HD
    BLESSING, JA
    RETTENMAIER, M
    CAPIZZI, RL
    MAJOR, FJ
    TWIGGS, LB
    [J]. OBSTETRICS AND GYNECOLOGY, 1988, 72 (03): : 413 - 418
  • [30] Optimal management of low-risk gestational trophoblastic neoplasia
    Goldstein, Donald P.
    Berkowitz, Ross S.
    Horowitz, Neil S.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1293 - 1304